Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma

(2015) Huanwen Wu et al.   PLoS One

Novel Mechanistic Insights into Ectodomain Shedding of EGFR Ligands Amphiregulin and TGF- : Impact on Gastrointestinal Cancers Driven by Secondary Bile Acids

(2014) N. S. Nagathihalli et al.   CANCER RESEARCH

Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression

(2014) Wai-Kin So et al.   FEBS LETTERS

Amphiregulin

(2014) Carmen Berasain et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

(2013) Hui K. Gan et al.   FEBS Journal

EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins

(2013) Adriana Handra-Luca et al.   JOURNAL OF CLINICAL PATHOLOGY

Aberrantly activated AREG–EGFR signaling is required for the growth and survival of CRTC1–MAML2 fusion-positive mucoepidermoid carcinoma cells

(2013) Z Chen et al.   ONCOGENE

Exosome-Bound WD Repeat Protein Monad Inhibits Breast Cancer Cell Invasion by Degrading Amphiregulin mRNA

(2013) Makio Saeki et al.   PLoS One

Postoperative Prognostic Predictors of Pancreatic Ductal Adenocarcinoma: Clinical Analysis and Immunoprofile on Tissue Microarrays

(2012) Joo Kyung Park et al.   ANNALS OF SURGICAL ONCOLOGY

Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy

(2012) H. K. Gan et al.   CANCER RESEARCH

Role of Epidermal Growth Factor Receptor Expression on Patient Survival in Pancreatic Cancer: A Meta-Analysis

(2012) Guopei Luo et al.   PANCREATOLOGY

The multiple roles of amphiregulin in human cancer

(2011) Benoit Busser et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment

(2011) I. Tinhofer et al.   CLINICAL CANCER RESEARCH

Amphiregulin Exosomes Increase Cancer Cell Invasion

(2011) James N. Higginbotham et al.   CURRENT BIOLOGY

Feedback regulation of EGFR signalling: decision making by early and delayed loops

(2011) Roi Avraham et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Plasma Transforming Growth Factor α and Amphiregulin Protein Levels in NCIC Clinical Trials Group BR.21

(2010) Christina L. Addison et al.   JOURNAL OF CLINICAL ONCOLOGY

The EGFRvIII variant in glioblastoma multiforme

(2009) Hui K. Gan et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer

(2008) Katsuhiro Masago et al.   CANCER SCIENCE

Amphiregulin Is a Promising Prognostic Marker for Liver Metastases of Colorectal Cancer

(2008) M. Yamada et al.   CLINICAL CANCER RESEARCH